NYSE · LH · Diagnostics & Research
Labcorp Holdings Inc. (LH) stock analysis
- LH gained 3.9% over the past month versus 0.0% for the S&P 500, ranking 212th of 497 S&P 500 stocks.
- Over 12 months it returned +11.9%, 3.9 points behind the S&P 500, and trades 4.6% below its 52-week high.
- In the last 30 days 3 analysts raised earnings estimates and 3 cut; forward EPS moved −0.3% (+1.9% over 90 days).
- It sits in the Clinical laboratory services segment of the Medtech, Diagnostics & Care, where the 1-month median return is +3.0%.
- The daily chart reads Trend transition · Trend repair (since Oct 20, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 20, 2026
- Close above EMA20 above EMA50
- EMA50 rose over the last ten sessions
- Confirmed swing highs and lows are rising
- Intermediate and long-term directions differ
- Neither a stable trend nor a range is confirmed
45 occurrences in 10 years. The median move over the next 20 sessions was +2.7%, positive 73% of the time, against +1.2% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
16 analysts cover the stock
Where it sits in the supply chain
Medtech, Diagnostics & Care · Devices, supplies & tests
Clinical testing turns samples into diagnostic information.
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.